u/milos_mensa
Contributes reviews on supplier material. Based in Nairobi.
member · joined 12 Mar 2025
Comments — page 4 of 4
comment on reading state board threads from 2024 and half of it aged badly in c/compounding · 58 points · 2 years ago
This is correct. The shortage list does expire and the rules change.
comment on small win: weekly update stopped being a problem at week 96 in c/dosinglogs · 6 points · 2 years ago
The injection-site soreness was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
comment on small win: weekly update stopped being a problem at week 96 in c/dosinglogs · 8 points · 2 years ago
Denmark here. Waited 8 months on a list, gave up, went private, and the total cost was roughly what I expected.
comment on small win: weekly update stopped being a problem at week 96 in c/dosinglogs · -9 points · 2 years ago
Slight fix: the number was 96.8, not 96.2. Decimal point, but a fairly consequential one.
comment on tried sequence for 24 weeks. here is what happened. in c/bpc157 · 8 points · 2 years ago
Genuine question — what concentration were you at?
comment on help me understand 503A, I have read the wiki twice in c/compounding · 97 points · 2 years ago
the the UK situation is different from the US, different regulations
comment on 19 months in and hepatic fat is still the thing I get wrong in c/survodutide · 4 points · 2 years ago
the GLP-1/glucagon dual is glucagon, different from GIP/GLP-1
comment on my ApoB moved and I cannot work out whether 503A is why in c/compounding · 23 points · 2 years ago
Yeah, 503A and 503B are different regulatory animals.
Disagree on that part. 99.2% and 95.1% on the same vial is normal.
comment on reading telehealth threads from 2024 and half of it aged badly in c/compounding · 3 points · 2 years ago
503B compounding is different from 503A, different rules, different legality
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.